Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Selectis Health (GBCS) EBIAT (2017 - 2025)

Selectis Health's EBIAT history spans 14 years, with the latest figure at -$804121.0 for Q4 2025.

  • Quarterly results put EBIAT at -$804121.0 for Q4 2025, down 39.49% from a year ago — trailing twelve months through Dec 2025 was -$1.1 million (up 56.28% YoY), and the annual figure for FY2025 was -$1.0 million, up 58.1%.
  • EBIAT for Q4 2025 was -$804121.0 at Selectis Health, down from $752365.0 in the prior quarter.
  • In the past five years, EBIAT ranged from a high of $4.0 million in Q1 2023 to a low of -$3.6 million in Q4 2023.
  • The 5-year median for EBIAT is -$689390.0 (2021), against an average of -$604593.4.
  • The sharpest move saw EBIAT crashed 1769.95% in 2022, then skyrocketed 10752.46% in 2023.
  • Year by year, EBIAT stood at -$1.8 million in 2021, then decreased by 23.97% to -$2.2 million in 2022, then plummeted by 65.73% to -$3.6 million in 2023, then skyrocketed by 84.13% to -$576463.0 in 2024, then plummeted by 39.49% to -$804121.0 in 2025.
  • According to Business Quant data, EBIAT over the past three periods came in at -$804121.0, $752365.0, and -$308027.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.